Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma

31

TOKYO–(BUSINESS WIRE)–Otsuka Chemical Co., Ltd. (Head office: Chuo-Ku, Osaka; President & Representative Director: Takeharu Harashima; hereinafter “Otsuka Chemical”) announces that it has succeeded part of the Cefixime business from Astellas Pharma, Inc. (Head Office: Chuo-Ku, Tokyo; President & CEO: Kenji Yasukawa, Ph.D.; hereinafter “Astellas Pharma”). Through this agreement, Otsuka Chemical acquires the business of Cefixime from Astellas Pharma to supply the API (Active Pharmaceuti…

 

http://www.businesswire.com/news/home/20190604006187/en/Otsuka-Chemical-Succeeded-Part-Cefixime-Business-Astellas/